Our investigation uncovers significant correlations between AIM2 expression and cancer-related processes and signaling pathways, thereby reinforcing AIM2’s involvement in CRC progression, particularly through P38 mitogen-activated protein kinase (P38MAPK). This evidence concerns the gene AIM2 and colorectal carcinoma.